Clinical trials exploring autologous CD133+ cell transplantation in patients with DMD have led to increased muscle vascularisation and transition of myosin-positive muscle fibers from slow to fast, but no notable improvements in muscle function [168]. Here, PROM1 is linked to Duchenne muscular dystrophy.